STRIDES PHARMA SCIENCE Share Price Up by 12%; BSE HEALTHCARE Index Up 0.8%

Fri, 26 Mar 02:48 PM

STRIDES PHARMA SCIENCE share price has zoomed 12% and is presently trading at Rs 833.

Meanwhile, the BSE HEALTHCARE Index is at 20,831 (up 0.8%).

Among the top Gainers in the BSE HEALTHCARE Index today is STRIDES PHARMA SCIENCE (up 11.6%).

JUBILANT PHARMOVA (down 0.1%) and FORTIS HEALTHCARE (down 0.2%) are among the top losers today.

Over the last one year, STRIDES PHARMA SCIENCE has moved up from Rs 300 to Rs 833, registering a gain of Rs 533 (up 177.0%).

On the other hand, the BSE HEALTHCARE has moved up from 11,264 to 20,831, registering a gain of 9,567 points (up 84.5%) during the last 12 months.

The top buzzing stocks among the BSE HEALTHCARE Index stocks during this same period were LAURUS LABS (up 435.4%), PIRAMAL ENTERPRISES (up 191.5%) and STRIDES PHARMA SCIENCE (up 177.0%).

JUST IN: Limited-Time Access to Full Transcript of Our Urgent Broadcast on India's Revival

What About the Benchmark Indices?

The BSE Sensex is at 49,235 (up 1.3%).

The top gainers among the BSE Sensex stocks today are TATA STEEL (up 6.6%), BAJAJ FINSERV (up 4.7%) and ASIAN PAINTS (up 4.0%). Other gainers include TITAN (up 3.5%) and HUL (up 3.4%). The most traded stocks in the BSE Sensex are SBI and TATA STEEL.

In the meantime, NSE Nifty is at 14,573 (up 1.3%). The top gainers in the NSE Nifty include TATA STEEL (up 6.2%), BAJAJ FINSERV (up 4.5%) and TATA MOTORS (up 4.3%). Other gainers include HINDALCO (up 4.0%) and ASIAN PAINTS (up 3.8%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 26,674 to 49,235, registering a gain of 22,561 points (up 83.87%).

STRIDES PHARMA SCIENCE Financial Update...

STRIDES PHARMA SCIENCE net profit down at Rs 621 million for the quarter ended December 2020, compared to a loss of Rs 1 billion a year ago. Net Sales rose 13.6% to Rs 8.3 billion during the period as against Rs 7.3 billion in October-December 2019.

For the year ended March 2018, STRIDES PHARMA SCIENCE reported 58.6% decrease in net profit to Rs 1.3 billion compared to net profit of Rs 3.2 billion during FY17.

Revenue of the company grew 3.0% to Rs 28 billion during FY18.

The current Price to earnings ratio of STRIDES PHARMA SCIENCE, based on rolling 12 month earnings, stands at 64.9x.

Indian Share Market Update: Top Gainers and Losers

What else is happening in the markets today? Dig in...